Emergent BioSolutions Inc... (EBS)
NYSE: EBS
· Real-Time Price · USD
8.85
0.03 (0.34%)
At close: Aug 15, 2025, 3:59 PM
8.82
-0.28%
After-hours: Aug 15, 2025, 07:40 PM EDT
Emergent BioSolutions Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 267.3M | 149.1M | 99.5M | 149.9M | 71M | 79M | 111.7M | 87.8M | 88.6M | 430.2M | 642.6M | 240.9M | 358.1M | 435.8M | 576.1M | 403.8M | 447.5M | 547.8M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.9M | 8.5M | 8.9M | 4.8M | 200K | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 400K | 1.5M | 2.3M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 12.5M | 13.1M | 26.1M | 20.5M | 5M | 176.1M | 178.1M | 194.1M | 194.6M | 184.6M | 191.3M | 35.7M | 51.3M | 57.1M | 57.3M | 102.2M | 109.9M | 111.4M |
Receivables | 79.8M | 203.7M | 154.5M | 121.3M | 196.3M | 233.5M | 191M | 216.5M | 290.1M | 155.9M | 159.2M | 191.3M | 175M | 181.8M | 274.7M | 254.6M | 261.9M | 184.4M |
Inventory | 338.6M | 314M | 311.7M | 322.7M | 317.5M | 333.4M | 328.9M | 354.1M | 354.3M | 367.9M | 351.8M | 546.3M | 425.5M | 400.7M | 350.8M | 364.6M | 386.4M | 406.5M |
Other Current Assets | 33.8M | 40M | 33M | 67.5M | 71M | 37M | 47.9M | 62.4M | 44.7M | 267.3M | 57.9M | 140M | 125.6M | 82M | 100K | 88.5M | 200K | 200K |
Total Current Assets | 719.5M | 706.8M | 598.7M | 661.4M | 654.5M | 682.4M | 679.5M | 354.1M | 777.7M | 1.22B | 1.21B | 1.12B | 1.08B | 1.1B | 1.27B | 1.11B | 1.16B | 1.18B |
Property-Plant & Equipment | 216.1M | 221M | 270.6M | 278.1M | 319.9M | 394.7M | 399M | 395.4M | 395.5M | 716.8M | 817.6M | 806.7M | 798.4M | 807.5M | 800.1M | 768.7M | 743.5M | 692.9M |
Goodwill & Intangibles | 469M | 485.2M | 501.5M | 517.8M | 534.1M | 550.4M | 566.6M | 582.8M | 811M | 827.1M | 947M | 947.6M | 801.5M | 815.5M | 829.5M | 885.1M | 899.7M | 914.7M |
Total Long-Term Assets | 697.6M | 719.3M | 791M | 816.4M | 859M | 1.12B | 1.16B | 1.17B | 1.4B | 1.73B | 1.96B | 1.79B | 1.65B | 1.68B | 1.69B | 1.76B | 1.75B | 1.72B |
Total Assets | 1.42B | 1.43B | 1.39B | 1.48B | 1.51B | 1.8B | 1.83B | 1.89B | 2.18B | 2.95B | 3.17B | 2.91B | 2.74B | 2.78B | 2.96B | 2.87B | 2.92B | 2.9B |
Account Payables | 63.7M | 58.1M | 60.9M | 82.1M | 95.9M | 100.2M | 112.2M | 112.7M | 108.3M | 124.2M | 103.5M | 103.8M | 106.2M | 107.3M | 128.9M | 135.2M | 151.8M | 142.2M |
Deferred Revenue | n/a | n/a | n/a | n/a | 6.2M | 5.5M | 27.2M | 22.9M | 100.8M | 12.8M | 26.4M | 24.8M | n/a | 10M | 140.4M | 116.3M | 97M | 80M |
Short-Term Debt | n/a | n/a | n/a | 800K | 415.2M | 462.5M | 413.7M | 413.6M | 455.2M | 950.7M | 957.3M | 21.2M | 31.6M | 31.6M | 31.6M | 31.6M | 28.8M | 26M |
Other Current Liabilities | 63.4M | 40.6M | 83.8M | 147M | 91.4M | 20M | 106.8M | 120.7M | 98.5M | 119.5M | 133.2M | 107.5M | 98.6M | 81M | 161.6M | 155.7M | 163.4M | 177M |
Total Current Liabilities | 127.1M | 111.9M | 162.4M | 229.9M | 619.7M | 630.2M | 651.3M | 664M | 693.2M | 1.22B | 1.23B | 268.4M | 276.7M | 249.2M | 373.8M | 365.4M | 377.8M | 370.2M |
Long-Term Debt | 667.8M | 665.7M | 663.7M | n/a | 447M | 446.7M | 446.5M | 448.2M | 448M | 447.7M | 448.5M | n/a | 793.6M | 801.5M | 809.4M | 817.3M | 825.2M | 833.1M |
Other Long-Term Liabilities | 39.5M | 35.4M | 39.1M | 697.6M | 14.2M | 2M | 62.3M | 16.7M | 10.3M | 11.1M | 26.7M | 1.06B | 37.6M | 31.1M | 33M | 39.3M | 40.5M | 41.9M |
Total Long-Term Liabilities | 753.8M | 761.5M | 744.5M | 739.5M | 507.5M | 509.5M | 534.3M | 531.9M | 529.3M | 531.5M | 553.7M | 1.19B | 945.5M | 955.9M | 966.2M | 979.4M | 993.7M | 1.01B |
Total Liabilities | 880.9M | 873.4M | 906.9M | 969.4M | 1.13B | 1.14B | 1.19B | 1.2B | 1.22B | 1.75B | 1.78B | 1.46B | 1.22B | 1.21B | 1.34B | 1.34B | 1.37B | 1.38B |
Total Debt | 667.8M | 665.7M | 663.7M | 800K | 876.8M | 922.2M | 877.5M | 413.6M | 903.2M | 1.4B | 1.41B | 1.05B | 825.2M | 833.1M | 841M | 848.9M | 854M | 859.1M |
Common Stock | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K |
Retained Earnings | -156.4M | -144.4M | -212.4M | -181.1M | -295.9M | -12.8M | -21.8M | 27.7M | 289.7M | 551M | 734M | 822M | 897.7M | 954.1M | 957.8M | 768.5M | 801.2M | 796.6M |
Comprehensive Income | -8.1M | -6.1M | -5.2M | -7.3M | -5.5M | -5.5M | -5.7M | -2.6M | -1.6M | 1M | 3.1M | -5.2M | -6.1M | -9.3M | -16.1M | -23.1M | -22.4M | -24.4M |
Shareholders Equity | 536.2M | 552.7M | 482.8M | 508.4M | 386.3M | 663.9M | 649.3M | 697.2M | 956.3M | 1.2B | 1.38B | 1.45B | 1.51B | 1.58B | 1.62B | 1.52B | 1.54B | 1.52B |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.9M | 8.5M | 9.3M | 6.3M | 2.5M | n/a | n/a | n/a | n/a |